IL6 and Alzheimer disease: While targets such as AKT1, IL-1β, and IL-6 are well-established in AD pathology, the novelty of our findings lies in demonstrating coordinated modulation of these interconnected pathways simultaneously across both neuronal and intestinal compartments.